Comparative Proteomic Studies of Serum from Patients with Hepatocellular Carcinoma

REFERENCES

• Bruix J, Boix L, Sala M, Focus on hepatocellular carcinoma. Cancer Cell. 2004;5:215–219.
   PubMed Web of Science ®Google Scholar
• Kim WR, Gores GJ, Benson JT, Mortality and hospital utilization for hepatocellular carcinoma in the United States. Gastroenterology. 2005;129:486–493
   PubMed Web of Science ®Google Scholar
• Qian MY, Yuwei JR, Angus P, Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital. J Gastroenterol Hepatol. 2010;25:951–956.
   Google Scholar
• Pawlotsky JM, Cocquerel L, Durantel D, HCV research 20 years after discovery: a summary of the 16th international symposium on hepatitis C virus and related viruses. Gastroenterology. 2010;138:6–12.
   Google Scholar
• Mendizabal M, Reddy KR. Current management of hepatocellular carcinoma. Med Clin North Am. 2009;93:885–900.
   PubMedGoogle Scholar
• Seow TK, Liang RC, Leow CK, Hepatocellular carcinoma: from bedside to proteomics. Proteomics. 2001;1:1249–1263.
   PubMed Web of Science ®Google Scholar
• Goldfarb LG, Park KY, Cervenáková L, Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat Genet. 1998;19:402–403.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Ren J, Liu H, Serum proteomic analysis from Bacteremic and Leucopenic rabbits. J Surg Res. 2010 May 22. [Epub ahead of print]
   Google Scholar
• Ito H, Takazoe M, Fukuda Y, A pilot randomized trial of human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease. Gastroenterology. 2004; 126:989–996.
   PubMed Web of Science ®Google Scholar
• Lautenbach E, Patel JB, Bilker WB, Extended-spectrum betalactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcome. Clin Infect Dis. 2001;32: 1162–1171.
   PubMed Web of Science ®Google Scholar
• Leibovici L, Drucker M, Samra Z, Prognostic significance of the neutrophil count in immuncompetent patients with bacteremia. QJM. 1995;88:181–189.
   Google Scholar
• Sellers, JR. Myosins: a diverse superfamily. Biochim Biophys Acta. 2000;1496:3–22.
   PubMed Web of Science ®Google Scholar
• Berg JS, Powell BC, Cheney RE. A millennial myosin census. Mol Biol Cell. 2001;12:780–794.
   PubMed Web of Science ®Google Scholar
• Vachani A, Nebozhyn M, Singhal S, A 10-gene classifier for distinguishing head and neck squamous cell carcinoma and lung squamous cell carcinoma. Clin Cancer Res. 2007;13:2905–2915.
   PubMed Web of Science ®Google Scholar
• Wiedenmann A, Dimroth P, von Ballmoos C. Functional asymmetry of the F(0) motor in bacterial ATP synthases. Mol Microbiol. 2009;72:479–490.
   Google Scholar
• Ackerman SH, Tzagoloff A. Function, structure, and biogenesis of mitochondrial ATP synthase. Prog Nucleic Acid Res Mol Biol. 2005;80:95–133.
   Google Scholar
• Schaefer AM, McFarland R, Blakely EL, Prevalence of mitochondrial DNA disease in adults. Ann Neurol. 2008;63:35–39.
   PubMed Web of Science ®Google Scholar
• Sperl W, Jesina P, Zeman J, Deficiency of mitochondrial ATP synthase of nuclear genetic origin. Neuromuscul Disord. 2006;16:821–829.
   Google Scholar
• Chang HJ, Lee MR, Hong SH, Identification of mitochondrial FoF1-ATP synthase involved in liver metastasis of colorectal cancer. Cancer Sci. 2007;98:1184–1191.
   Google Scholar
• Sylvester SR, Morales C, Oko R, Localization of sulfated glycoprotein-2 (clusterin) on spermatozoa and in the reproductive tract of the male rat. Biol Reprod. 1991;45:195–207.
   PubMed Web of Science ®Google Scholar
• Tung PS, Burdzy K, Wong K, Competition between cell–substratum interaction and cell–cell interactions. J Cell Physiol. 1992;152:410–421.
   PubMedGoogle Scholar
• Jenne DE, Tschopp J. Clusterin: the intriguing guises of a widely expressed glycoprotein. Trends Biochem Sci. 1992;17:154–159.
   PubMed Web of Science ®Google Scholar
• Tenniswood MP, Guenette RS, Lakins J, Active cell death in hormone-dependent tissues. Cancer Metastasis Rev. 1992;11:197–220.
   PubMed Web of Science ®Google Scholar
• Michel D, Moyse E, Trembleau A, Clusterin/ApoJ expression is associated with neuronal apoptosis in the olfactory mucosa of the adult mouse. J Cell Sci. 1997;110:1635–1645.
   Google Scholar
• Griswold MD, Roberts K, Bishop P. Purification and characterization of a sulfated glycoprotein secreted by Sertoli cells. Biochemistry. 1986;25:7265–7270.
   PubMed Web of Science ®Google Scholar
• Aronow BJ, Lund DS, Brown TL, Apoprotein J expression at fluid–tissue interfaces: potential role in barrier cytoprotection. Proc Natl Acad Sci USA. 1993;90:725–729.
   PubMed Web of Science ®Google Scholar
• Humphreys D, Hochgrebe TT, Easterbrook-Smith SB, Effects of clusterin overexpression on TNF alpha- and TGF beta-mediated death of L929 cells. Biochemistry. 1997;36:15233–15243.
   PubMedGoogle Scholar
• Fuchs, E. The cytoskeleton and disease: genetic disorders of intermediate filaments. Annu Rev Genet. 1996;30:197–231.
   PubMedGoogle Scholar
• Duffy PE, Huang YY, Rapport MM. The relationship of glial fibrillary acidic protein to the shape, motility, and differentiation of human astrocytoma cells. Exp Cell Res. 1982;139:145–157.
   Google Scholar
• Toda M, Miura M, Asou H, Cell growth suppression of astrocytoma C6 cells by glial fibrillary acidic protein cDNA transfection. J Neurochem. 1994;63:1975–1978.
   Google Scholar
• Okamura N, Yoshida M, Shibuya A, Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas. Pathol Int. 2005;55:724–731.
   Google Scholar